Last update June 1, 2017
Very Low Risk
A keratolytic and topical anti-infective agent used in the treatment of acne.
Since the last update we have not found published data on its excretion in breast milk
Only 5% is absorbed through the skin and is quickly eliminated via urine after being metabolized in the skin to benzoic acid (AEMPS 2013, Seubert 1984, Holzmann 1979), so it is not expected to pass into breast milk.
Taken orally, it is destroyed at the gastrointestinal level, so its absorption into milk is zero.
It is considered very low risk during breastfeeding (Kong 2013, Worret 2006, Leachman 2006, Zip 2002).
Do not apply to the chest in order to prevent the infant from ingesting it; if necessary, apply after breastfeeding and clean well with water before the next feed. Applying topical creams, gels and other products which contain paraffin (mineral oil) to the nipple is to be avoided so that the infant does not absorb them. (Concin 2008, Noti 2003).
List of essential medicines WHO: compatible with breastfeeding (WHO / UNICEF 2002).
We do not have alternatives for 過酸化ベンゾイル since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM